Lipocine (STU:2VT0) Shiller PE Ratio: (As of Sep. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2VT0 Lipocine Inc STU:2VT0
49 GF Score
Price €3.94
GF Value €2.32
! 4 Warning Signs
View Full Analysis

What is Lipocine Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lipocine  (STU:2VT0) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Lipocine Shiller PE Ratio Related Terms


Lipocine Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Lipocine's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipocine Shiller PE Ratio Chart

Lipocine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Lipocine Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:2VT0 vs TPST, CYCN, BCDA: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Lipocine's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipocine Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipocine's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lipocine's Shiller PE Ratio falls into.


STU:2VT0
49GF Score
Lipocine Inc STU:2VT0
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lipocine Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lipocine's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Lipocine's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.278/333.9520*333.9520
=-0.278

Current CPI (Jun. 2026) = 333.9520.

Lipocine Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -2.726 241.428 -3.771
201612 -2.579 241.432 -3.567
201703 -4.133 243.801 -5.661
201706 -4.690 244.955 -6.394
201709 -3.138 246.819 -4.246
201712 -3.591 246.524 -4.865
201803 -1.792 249.554 -2.398
201806 -2.183 251.989 -2.893
201809 -1.748 252.439 -2.312
201812 -2.241 251.233 -2.979
201903 -2.106 254.202 -2.767
201906 -2.106 256.143 -2.746
201909 -1.852 256.759 -2.409
201912 -1.530 256.974 -1.988
202003 -2.154 258.115 -2.787
202006 -1.962 257.797 -2.542
202009 -1.010 260.280 -1.296
202012 -0.838 260.474 -1.074
202103 -0.571 264.877 -0.720
202106 -1.129 271.696 -1.388
202109 -0.578 274.310 -0.704
202112 2.106 278.802 2.523
202203 -0.617 287.504 -0.717
202206 -0.577 296.311 -0.650
202209 -0.525 296.808 -0.591
202212 -0.406 296.797 -0.457
202303 -0.710 301.836 -0.786
202306 -0.628 305.109 -0.687
202309 -1.190 307.789 -1.291
202312 -0.385 306.746 -0.419
202403 0.607 312.332 0.649
202406 -0.530 314.175 -0.563
202409 -0.396 315.301 -0.419
202412 0.315 315.605 0.333
202503 -0.324 319.799 -0.338
202506 -0.355 322.561 -0.368
202509 -0.503 324.800 -0.517
202512 -0.359 324.054 -0.370
202603 -0.467 330.213 -0.472
202606 -0.278 333.952 -0.278

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Lipocine (STU:2VT0) Overvalued in 2026?

Based on GuruFocus' analysis, Lipocine stock appears to be overvalued. The current stock price of €3.94 is trading 70% above its estimated GF Value™ of €2.32.

Key valuation signals for STU:2VT0:

  • Shiller PE Ratio:
  • GF Value™: €2.32 vs. price of €3.94 (70% above fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the STU:2VT0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lipocine Business Description

Other Exchanges LPCN:USA
Address 675 Arapeen Drive, Suite 202, Salt Lake City, UT, USA, 84108
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
49GF Score

Get the complete analysis for STU:2VT0

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.94
Price
€2.32
GF Value